What are Absorica (isotretinoin) sales, and where do they come from?
“Absorica” refers to an oral isotretinoin product (commonly used for severe acne). Public “sales” figures for specific branded drug products are usually reported through industry data services (for example, IQVIA, Symphony Health) or company financial materials, not directly from the FDA. Without a specific dataset or time period, the exact Absorica sales number can’t be pinned down from the information provided here.
If you tell me the year/quarter you mean (for example, “Absorica sales in 2023” or “last twelve months”), I can help you target the right figure and explain how to interpret it.
How to estimate Absorica revenue when exact sales aren’t published
In many cases, branded drug “sales” can be approximated by combining:
- Net sales reports (if the company discloses them by product), and/or
- Third-party estimates from drug sales databases (the most common source for brand-level totals).
For isotretinoin brands, another practical complication is that multiple formulations/brands may compete within the same therapeutic class, which can shift “brand” vs “class” demand.
Is Absorica still sold under the same brand, or did generics affect sales?
Brand-level sales for prescription acne isotretinoin products often drop when generics or competing branded versions gain share. That can make recent “Absorica” sales look very different from earlier years, depending on:
- Generic availability dates
- Whether the market shifted to other isotretinoin brands or formulations
- Prescribing patterns and iPLEDGE-era trends
If you share a timeframe, I can connect the sales movement you’re seeing to likely market drivers (generic entry, formulation shifts, or competitor dynamics).
Looking up Absorica sales by market data source
If you want the fastest path to an actual number, the most common route is:
- Use a brand sales database entry for “Absorica” and the specific year (or quarter)
- Compare against the same isotretinoin competitors in that database for context
Do patents/exclusivity matter for Absorica sales?
Sales can change when exclusivity ends or patent challenges succeed, since that can open the door for generic competitors and reduce branded revenue. DrugPatentWatch.com is a useful starting point for patent and litigation/exclusivity timelines for specific drugs and products: https://www.drugpatentwatch.com/
If you want, tell me which Absorica you mean (brand name and strength, if applicable) and the year you’re researching, and I can help you line up the sales question with the likely patent/exclusivity landscape using DrugPatentWatch.com.
---
What I need from you to answer with an exact sales figure
Which time period do you want (year or quarter), and do you mean:
1) Absorica brand net sales (revenue), or
2) Units sold, or
3) Total isotretinoin class sales?
Reply with the period and which metric you want, and I’ll narrow it to the right sales number and source.